跳至主要内容
临床试验/NCT07241741
NCT07241741已完成不适用

A Single-Center Prospective Study on PTX3 as a Predictor of Insulin Resistance and Inflammatory Resolution After Bariatric Surgery

Istanbul University0 个研究点目标入组 23 人开始时间: 2015年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
23
主要终点
Change in HOMA-IR from baseline to 6 months

研究概览

简要总结

This study evaluated the prognostic value of preoperative pentraxin-3 (PTX3) levels in predicting weight loss, inflammatory resolution (CRP, IL-6), and metabolic improvements (HOMA-IR) following Roux-en-Y gastric bypass in patients with obesity.

详细描述

This single-center longitudinal study was conducted at Istanbul University Hospital. A total of 23 patients undergoing primary Roux-en-Y gastric bypass were included. PTX3 levels were measured preoperatively, and patients were stratified according to a data-derived cut-off (~21.7 ng/mL). Outcomes assessed at baseline, 3 months, and 6 months included body weight, BMI, excess weight loss (%EWL), fasting insulin, HOMA-IR, CRP, and IL-6. The primary hypothesis was that preoperative PTX3 would predict postoperative CRP normalization and insulin resistance improvement.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Days 至 65 Days(Child)
性别
All
接受健康志愿者

入选标准

  • Age: 18-65 years
  • Body mass index (BMI) ≥40 kg/m², or BMI ≥35 kg/m² with obesity-related comorbidity
  • Eligible for primary Roux-en-Y gastric bypass
  • Able to provide written informed consent

排除标准

  • Previous bariatric surgery
  • Severe hepatic, renal, or cardiac failure
  • Active infection or inflammatory disease
  • Malignancy

结局指标

主要结局

Change in HOMA-IR from baseline to 6 months

时间窗: Baseline, 3 months, 6 months

Assessment of the improvement in insulin resistance after Roux-en-Y gastric bypass, measured by the homeostasis model assessment of insulin resistance (HOMA-IR). Preoperative PTX3 stratification will be used to evaluate predictive value.

次要结局

  • Percent Excess Weight Loss (%EWL) at 6 months(6 months)
  • CRP normalization at 6 months(6 months)
  • Change in IL-6 from baseline to 6 months(Baseline, 3 months, 6 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Fulya Calikoglu

Lecturer

Istanbul University

相似试验